Medherant Limited
Medherant develops drug delivery products for pain and CNS diseases using its proprietary TEPI Patch technology.
17 employees · est. 2015 · Coventry, United Kingdom
Vaxess Technologies
Forging a path to more convenient, self-empowered, and accessible healthcare
61 employees · est. 2012 · Boston, United States
Vaxess Technologies is the older company (2015 vs 2012); Vaxess Technologies is the larger of the two.
Side-by-Side Comparison
| Metric | Medherant Limited | Vaxess Technologies |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2012 older |
| Headquarters | ||
| Headquarters | Coventry, United Kingdom | Boston, United States |
| Employees | ||
| Employees | 17 | 61 larger |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Unknown | Series Unknown |
| Total Funding | ||
| Total Funding | $11.22M | $83.24M |
| Funding Rounds | ||
| Funding Rounds | 6 | 15 |
| Services | ||
| Services | development and distribution of transdermal patches, clinical trials for product efficacy and safety, hormone therapy product innovation | Development of microarray patch platforms, Delivery of next-gen therapies using MAP, Temperature stable drug delivery solutions |
| Target Customers | ||
| Target Customers | postmenopausal women, healthcare providers, pharmaceutical distributors | Patients seeking convenient healthcare solutions, Individuals needing temperature stable treatments, Healthcare providers looking for innovative delivery methods |
| Taxonomy | ||
| Taxonomy | Transdermal Drug Delivery, TEPI Patch Technology, Bioadhesive Development, Polymer Chemistry, Pain Management, CNS Disease Treatments, Drug Formulation, Pharmaceutical Feasibility Studies, High Drug Loading Capacity, Customizable Drug Release, Skin Adhesion, Moisture Resistant Technology, Pharmaceutical Excipients, Licensing For Commercialization, Drug Delivery Innovation | Microarray Patch Technology, Sustained Release Vaccines, Next-Generation Therapies, Dose Delivery Control, Non-Refrigerated Delivery, Low-Resource Settings Delivery, Therapeutic Patch Platforms, Biomaterials Innovation, Immune Response Enhancement, Venture Capital Funding, Clinical Proof Of Concept, In-vivo Efficacy, Stability Engineered Solutions, Grant Funding From Health Agencies, Payload Customization |
| Website | ||
| Website | medherant.co.uk | vaxess.com |
About Medherant Limited
Medherant Limited, founded in 2015, is a United Kingdom-based clinical-stage company specializing in innovative drug delivery systems targeting pain and CNS diseases. Utilizing its proprietary TEPI Patch technology, developed from a unique adhesive created by Professor David Haddleton and the Univer...
About Vaxess Technologies
Vaxess Technologies, established in 2012, is positioning itself as a transformative force in the Biotechnology and Health Care industries. The company is dedicated to making healthcare more convenient, self-empowered, and accessible through its innovative delivery platform. The platform features a...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Medherant Limited and Vaxess Technologies — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Medherant Limited and Vaxess Technologies — by email.
Frequently Asked Questions
Compare Medherant Limited with someone else
Start typing a company name or domain.